Rhoen Klinikum AG
XETRA:RHK

Watchlist Manager
Rhoen Klinikum AG Logo
Rhoen Klinikum AG
XETRA:RHK
Watchlist
Price: 12.3 EUR Market Closed
Market Cap: €823.6m

P/S

0.5
Current
11%
Cheaper
vs 3-y average of 0.5

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0.5
=
Market Cap
€836.7m
/
Revenue
€1.7B

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0.5
=
Market Cap
€836.7m
/
Revenue
€1.7B

Valuation Scenarios

Rhoen Klinikum AG is trading below its 3-year average

If P/S returns to its 3-Year Average (0.5), the stock would be worth €13.75 (12% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+141%
Average Upside
73%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 0.5 €12.3
0%
3-Year Average 0.5 €13.75
+12%
5-Year Average 0.6 €14.94
+21%
Industry Average 1.2 €29.69
+141%
Country Average 1.1 €26.85
+118%

Forward P/S
Today’s price vs future revenue

Today's Market Cap Revenue Forward P/S
€836.7m
/
Jan 2026
€1.7B
=
0.5
Current
€836.7m
/
Dec 2026
€1.7B
=
0.5
Forward
€836.7m
/
Dec 2027
€1.9B
=
0.4
Forward
€836.7m
/
Dec 2028
€2B
=
0.4
Forward
€836.7m
/
Dec 2029
€2.1B
=
0.4
Forward
€836.7m
/
Dec 2030
€2.2B
=
0.4
Forward

Forward P/S shows whether today’s P/S still looks high or low once future revenue are taken into account.

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close

Market Distribution

Lower than 77% of companies in Germany
Percentile
23nd
Based on 2 778 companies
23nd percentile
0.5
Low
0 — 0.6
Typical Range
0.6 — 2.1
High
2.1 —
Distribution Statistics
Germany
Min 0
30th Percentile 0.6
Median 1.1
70th Percentile 2.1
Max 23 633

Rhoen Klinikum AG
Glance View

Market Cap
823.6m EUR
Industry
Health Care

Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern and currently employs 18,227 full-time employees. The company operates acute hospitals, medical care centers and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic Clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.

RHK Intrinsic Value
16.57 EUR
Undervaluation 26%
Intrinsic Value
Price €12.3
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett